GlobeNewswire Inc | Apr 28, 2021 07:01AM EDT

April 28, 2021

CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc.(Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast onWednesday, May 5, 2021, at8:00 a.m. ETto discuss a corporate update and results for the first quarter of 2021.

Conference Call & Webcast DetailsDate: Wednesday, May 5, 2021Time: 8:00 am Eastern TimeToll Free: (844) 348-3801International: (213) 358-0955Conference ID: 7587147Webcast: https://edge.media-server.com/mmc/p/vfqo9b5q

The live webcast of the conference call can also be accessed in the Investors section of Editas Medicine website at https://www.editasmedicine.com/.

AboutEditas MedicineAs a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.

Contacts:MediaCristi Barnett(617) 401-0113cristi.barnett@editasmed.com

InvestorsRon Moldaver(617) 401-9052ir@editasmed.com